Interviews From The ADC Summit

Interview with Robin Silva

Interview With Nahor Haddish-Berhane

Click here to download.

Interview With Mike Wheatcroft

Interview With Fred Jacobson, Genentech

Road to the World ADC Summit:

Interview with Michael Buckley, Vice President, Process Sciences, Takeda San Francisco

Dr. Buckley has more than 20 years' experience in the biotechnology development and manufacturing sectors for both clinical candidates and commercially approved Monoclonal Antibody products. He previously has held executive positions with  Neugenesis Corporation, Genitope Corporation and Corixa Corporation, leading multi-disciplinary groups in process development, manufacturing and materials management. Presently, he is leading the Process Science function at Takeda San Francisco, responsible for the CMC preclinical development of lead Ab candidates. He also has written multiple IND, BLA and drug master file sections for regulatory submissions. While at Corixa, Dr. Buckley was instrumental in the development of the first centrally manufactured radiopharmaceutical-Iodine-131 antibody (Bexxar(TM)). He holds a PhD in immunology from the UMDNJ Graduate School of Biomedical Sciences, Newark, NJ. He received his B.A. in Biology from the College of Wooster, Wooster, Ohio.

Road to the World ADC Summit: Interview with John Lambert, CSO & EVP of ImmunoGen

To celebrate the upcoming World ADC Summit, I met with John Lambert, the CSO and EVP of ImmunoGen. He shared with me his thoughts on the vast progress that antibody-drug conjugates have made in recently years. Watch this video to find out about ImmunoGen’s most exciting projects, approaches to target selection, promising payload technologies, engineering advances, and the impact that a regulatory approval could have on the entire ADC Field.

Katie McQue, Program Director, World ADC Summit